Mostrando 10 resultados de: 16
Publisher
Bone(2)
Journal of Neural Transmission(2)
Pharmacology Biochemistry and Behavior(2)
Archives of Osteoporosis(1)
Behavioural Brain Research(1)
Área temáticas
Farmacología y terapéutica(12)
Enfermedades(11)
Fisiología humana(10)
Ginecología, obstetricia, pediatría, geriatría(3)
Temas específicos de historia natural de los animales(2)
Área de conocimiento
Neuropsicología(7)
Farmacología(4)
Fisiología(3)
Biología del desarrollo(1)
Biomedicina(1)
Origen
scopus(16)
Chronic exposure to methylphenidate impairs appendicular bone quality in young rats
ArticleAbstract: Methylphenidate (MP) is a psychostimulant widely prescribed to treat Attention Deficit HyperactivityPalabras claves:Biomechanics, DXA, Growth suppression, methylphenidate, TestosteroneAutores:Ananth M., David Edward Komatsu, Hadjiargyrou M., Janda H.A., John C.M., Mary M.N., Robison L.S., Swanson J.M., Thanos P.K., Volkow N.D.Fuentes:scopusChronic oral methylphenidate treatment in adolescent rats promotes dose-dependent effects on NMDA receptor binding
ArticleAbstract: Aim: Examine the effects of chronic oral Methylphenidate (MP) treatment on the N-Methyl-D-aspartic aPalabras claves:ADOLESCENCE, methylphenidate, NMDA, ritalinAutores:David Edward Komatsu, Delis F., Hadjiargyrou M., Hamilton J., Jalloh K., Roeder N., Thanos P.K.Fuentes:scopusChronic oral methylphenidate treatment increases microglial activation in rats
ArticleAbstract: Methylphenidate (MP) is a widely prescribed psychostimulant used to treat attention deficit hyperactPalabras claves:Attention Deficit Hyperactivity Disorder, Autoradiography, inflammation, methylphenidate, Microglia, ritalinAutores:Carias E., David Edward Komatsu, Delis F., Eiden R., Hadjiargyrou M., Hamilton J., Quattrin T., Robison L.S., Thanos P.K.Fuentes:scopusChronic oral methylphenidate treatment reversibly increases striatal dopamine transporter and dopamine type 1 receptor binding in rats
ArticleAbstract: Previously, we created an 8-h limited-access dual bottle drinking paradigm to deliver methylphenidatPalabras claves:dopamine, methylphenidate, Psychostimulant, Reward deficiency syndrome, reward, addiction, TransporterAutores:Ananth M., David Edward Komatsu, Hadjiargyrou M., Robison L.S., Thanos P.K.Fuentes:scopusChronic treatment and abstinence from methylphenidate exposure dose-dependently changes glucose metabolism in the rat brain
ArticleAbstract: Methylphenidate (MP) is extensively prescribed for attention deficit hyperactivity disorder (ADHD).Palabras claves:Brain Glucose Metabolism, FDG, imaging, methylphenidate, PetAutores:Blum K., David Edward Komatsu, Delis F., Fricke D., Hadjiargyrou M., Hamilton J., Martin C., Richer K., Sajjad M., Thanos P.K., Yao R.Fuentes:scopusCombined methylphenidate and fluoxetine treatment in adolescent rats significantly impairs weight gain with minimal effects on skeletal development
ArticleAbstract: Methylphenidate (MP) is frequently prescribed to treat Attention-Deficit/Hyperactivity Disorder (ADHPalabras claves:Fluoxetine, methylphenidate, RAT, Skeletal developmentAutores:Areikat N., Chirokikh A.A., Connor C., David Edward Komatsu, Duque E., Hadjiargyrou M., Jones R., Thanos P.K., Uddin S.M.Z.Fuentes:scopusBehavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
ReviewAbstract: The majority of animal studies on methylphenidate (MP) use intraperitoneal (IP) injections, subcutanPalabras claves:ADHD, animal model, Behavior, dopamine, methylphenidate, neurochemistry, Psychostimulant, ritalinAutores:Ahmed R., Arnavut E., Badgaiyan R.D., Blum K., Carvalho A., David Edward Komatsu, Hadjiargyrou M., Lee W.X., Senior D., Thanos P.K.Fuentes:scopusBrief and extended abstinence from chronic oral methylphenidate treatment produces reversible behavioral and physiological effects
ArticleAbstract: Methylphenidate (MP) is a commonly prescribed psychostimulant to individuals with Attention DeficitPalabras claves:anxiety, Attention Deficit Hyperactivity Disorder, methylphenidate, Psychostimulant, ritalinAutores:Carias E., Connor C., David Edward Komatsu, Hadjiargyrou M., Kalinowski L., Mackintosh M., Martin C., Popoola D., Richer K., Smith L., Somanesan R., Thanos P.K.Fuentes:scopusA pharmacokinetic model of oral methylphenidate in the rat and effects on behavior
ArticleAbstract: Most animal studies using methylphenidate (MP) do not administer it the same way it is administeredPalabras claves:Attention Deficit Hyperactivity Disorder, Dopamine transporter, methylphenidate, Psychostimulant, ritalinAutores:Cooper T., David Edward Komatsu, Hadjiargyrou M., Hwang Y., Robison L.S., Steier J., Swanson J.M., Thanos P.K., Volkow N.D.Fuentes:scopusAbstinence following intermittent methylphenidate exposure dose-dependently modifies brain glucose metabolism in the rat brain
ArticleAbstract: Methylphenidate (MP) is a psychostimulant chronically prescribed for the treatment of attention defiPalabras claves:Abstinence, addiction, brain function, FDG, Functional connectivity, glucose utilization, methylphenidate, microPET, PetAutores:Arnavut E., David Edward Komatsu, Hadjiargyrou M., Hamilton J., Sajjad M., Thanos P.K., Yao R.Fuentes:scopus